You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

  1. Home
  2. Clinical Information
  3. Performance Measures
  4. Intermediate Outcome

Intermediate Outcome

    Do Not Support
    • Group/Practice
    • Health Plan
    • Individual Clinician
    • Population: Regional and State

    Adherence to Antipsychotic Medications for Individuals with Schizophrenia

    Percentage of individuals at least 18 years of age as of the beginning of the measurement period with schizophrenia or schizoaffective disorder who had at least two prescription drug claims for antipsychotic medications and had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the measurement period (12 consecutive months).

    Date Reviewed: November 4, 2018

    Do Not Support: Uncertain Validity
    • Group/Practice
    • Individual Clinician

    Hypertension Improvement in Blood Pressure

    Percentage of patients aged 18-85 years of age with a diagnosis of hypertension whose blood pressure improved during the measurement period.

    Date Reviewed: November 19, 2017

    Do Not Support
    • Group/Practice
    • Individual Clinician

    Ischemic Vascular Disease: All or None Outcome Measure

    The IVD All-or-None Measure is one outcome measure (optimal control). The measure contains four goals. All four goals within a measure must be reached in order to meet that measure. The numerator for the all-or-none measure should be collected from the organization's total IVD denominator. All-or-None Outcome Measure (Optimal Control) - Using the IVD denominator optimal results include: Most recent blood pressure (BP) measurement is less than 140/90 mm Hg -- And Most recent tobacco status is Tobacco Free -- And Daily Aspirin or Other Antiplatelet Unless Contraindicated -- And Statin Use

    Date Reviewed: November 19, 2017

    Support
    • Group/Practice
    • Health Plan
    • Individual Clinician
    • Integrated Delivery System

    Persistence of Beta-Blocker Treatment After a Heart Attack

    The percentage of patients 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who were prescribed persistent beta-blocker treatment for six months after discharge.

    Date Reviewed: November 19, 2017